Ibudilast was shown on MRI scans to slow the growth of chronic active lesions in the brains of progressive MS patients in the SPRINT-MS trial.| Multiple Sclerosis News Today
The new intravenous formulation of ibudilast is expected to be useful for ALS patients who can't take medicine by mouth.| ALS News Today